Tag Archives: DCGI

Clinical Trials: How to get things right?

Posted on May 29, 2017 by Editor

The issue of Clinical Trials in India has once again come to the fore with the government’s efforts to woo the mighty pharma industry. The Drug Controller General of India, Mr G N Singh, has been quoted as saying that India will soon roll out a new policy to facilitate clinical trials. It is hence important to understand what are we talking about and why we need to get it right.

Posted in EDITOR'S CHOICE, OPINIONS, The Antagoniser | Tagged Bayer, Clinical Trials, CTRI, DCGI, Dr Kamal Mahawar, G N Singh, Make in India, Marijn Dekkers, Pharmaceutical Industry | Leave a comment

PGI Chandigarh to organise conference on organ transplant | PGI director Dr Yogesh Chawla’s tenure comes to an end

Posted on October 6, 2016 by Editor

As the tenure of PGI director Dr Yogesh Chawla ends on Thursday, dean of the institute, Dr Subhash Verma, has been asked by the union health ministry to take over as PGI director until the new director is appointed.

Posted in MEDICAL NEWS DIGEST | Tagged AIIMS, Bombay High Court, Conference, DCGI, Dengue Vaccine, Dengvaxia, Dr Anjan Trikha, Dr G C Khilnani, Dr Nitish Naik, Dr Richard Beale, Dr Subhash Verma, Dr Yogesh Chawla, Grant Medical College, Jayalalithaa, MBBS, MCI, Medipark, National Medical Commission, Organ Transplant, PGI Chandigarh, RTI, Rural Service, Sanofi Pasteur, Service Bond | Leave a comment

AIIMS to host World Trauma Congress from Aug 17-20 | Search committee set up for selection of new PGI chief | Govt amends clinical trial procedures

Posted on August 9, 2016 by Editor

The All India Institute of Medical Sciences (AIIMS), New Delhi will host the World Trauma Congress 2016 from August 17 to 20. According to a recent WHO report, by 2020, trauma will be the third largest killer in the developing world.

Posted in MEDICAL NEWS DIGEST | Tagged AIIMS, Clinical Trial, DCGI, Doctor Arrested, Dr S K Agnihotri, Dr Yogesh Chawla, J P Nadda, Kitten MRI, Medical Entrance Test, Mental Healthcare Bill, NEET, PGI Chandigarh, PGIMER, Telemedicine, World Trauma Congress | Leave a comment

Avastin not approved for intravitreal use for ophthalmology purposes

Posted on January 22, 2016 by Editor

New Delhi: The Drugs Controller General of India (DCGI) on Thursday issued an alert, asking states to ensure Swiss drugmaker Roche’s cancer treatment drug Avastin is not administered to treat eyes.

Posted in NEWS, Pharmaceuticals | Tagged Avastin, CH Nagri Eye Hospital, DCGI, Roche | Leave a comment

Nanomeds, combating dengue, 3D printing trended in India

Posted on December 23, 2015 by Editor

Kolkata: India became the world’s third country with the prowess to manufacture raw materials for nanomedicines, addressed a growing public health concern by approving a new drug for hepatitis C and made strides in 3D printing in healthcare as 2015 ended on a cliff-hanger with the launch of the world’s first anti-dengue vaccine in Mexico giving hope to the South Asian country.

Posted in FEATURES | Tagged 3D Printing, BioNaP, DCGI, Dengue, Dengue Vaccine, Dengvaxia, Dr Rajesh Kumar, GIAN, Healthcare, Hepatitis C Drug, High Cholesterol Food, IISER, International Year of Light, NanoCrySP, Nanomedicines, Nanotechnology, Nico Verdonschot, NIPER, Nirmalya Ghosh, Public Health, Sanofi Pasteur, Stratasys, Teixobactin | Leave a comment

Female viagra will take years to reach India: Doctors

Posted on August 20, 2015 by Editor

New Delhi: The newly-developed female viagra “Addyi” will take at least three to four years to be introduced in the Indian market as trials are still on to ascertain its long-term effects, doctors said on Thursday.

Posted in NEWS, Pharmaceuticals | Tagged Addyi, AIIMS, DCGI, Dr J B Sharma, Dr Nupur Gupta, Female Viagra, US FDA | Leave a comment

FDA orders FIR against Snapdeal.com top brass

Posted on May 1, 2015 by Editor

Mumbai (IANS): The Maharashtra Food and Drugs Administration (FDA) has ordered the filing of a first information report (FIR) against e-commerce major Snapdeal.com’s CEO, directors and distributors on charges of selling prescription drugs online, a top official said here on Friday.

Posted in NEWS, Pharmaceuticals | Tagged Amazon.com, Ascoril, DCGI, Drugs and Cosmetics Act 1940, eCommerce, FIR, Flipkart, Harshdeep Kamble, I-Pill, Jasper Infotech, Kunal Bahl, Maharashtra FDA, Schedule H Drugs, Sildenafil Citrate, Snapdeal, Unwanted-72, Vigora | Leave a comment

Private cord blood banks are fooling the public, say doctors

Posted on April 25, 2015 by Editor

Bengaluru (IANS): Cord blood banking (CBB) with dubious benefits has become a money-making scam in India and needs tighter control to protect gullible parents from being exploited, top medical researchers say.

Posted in NEWS | Tagged Banned, CBB, Cord Blood, Cryo Stemcell, DBT, DCGI, Deepa Bhartiya, Foundation for Research in Genetics and Endocrinology, HLA, ICMR, Jayesh Sheth, Jyothsna Rao, Kasiak Research, Krithika Narayanan, LifeCell, National Institute of Research in Reproduction, Satish Totey, Scam, Society of Regenerative Medicine and Tissue Engineering, Stem Cells, US FDA | 2 Comments

‘Drug controller impedes haemophilia care in India’

Posted on April 17, 2015 by Editor

New Delhi (IANS): Haemophilia care providers on Friday urged India’s drug regulator to be more sensitive to their needs and quickly clear the import of medicines donated from abroad.

Posted in NEWS | Tagged DCGI, Haemophilia, Haemophilia Care, Haemophilia Federation of India, Manoj Jhalani, Meenakshi Lekhi, S S Roychoudhury, WFH, World Haemophilia Day | Leave a comment

Recently approved Hepatitis C drug to help treat more patients

Posted on April 11, 2015 by Editor

New Delhi: A study conducted by researchers from the department of gastroenterology, Sir Ganga Ram Hospital on 777 patients of Hepatitis C from 2008 to 2014 reveals that the currently available treatment regimen in India for Hepatitis C could cure only 14 per cent of the patients.

Posted in NEWS, Pharmaceuticals | Tagged DAA, DCGI, Dr Anil Arora, FDA, HCV, Hepatitis C, Peginterferon, Ribavirin, Sir Ganga Ram Hospital, Sofosbuvir, SVR | Leave a comment